Clinical Trial Update: The Triglyceride Lowering Effect of an Omega-3 Fat (DHA) in Addition to Statin Therapy for Patients With CAD or Diabetes [NA]

View source ↗

Summary

This clinical trial update reports on the triglyceride-lowering effect observed when adding docosahexaenoic acid (DHA) to statin therapy in patients with corona…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Diabetes Mellitus
• Hyperlipidemia
• Hypertriglyceridemia

Drugs mentioned

• Docosahexaenoic acid (DHA) (docosahexaenoic acid)

Snippet

Sponsor: Maine Center for Lipids and Cardiovascular Health | Conditions: Hypertriglyceridemia (TG>200<500), Hyperlipidemia | NA | Status: COMPLETED